Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
    Biederman, Joseph
    Melmed, Raun D.
    Patel, Anil
    McBurnett, Keith
    Konow, Jennifer
    Lyne, Andrew
    Scherer, Noreen
    PEDIATRICS, 2008, 121 (01) : E73 - E84
  • [32] Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Tobias Banaschewski
    Mats Johnson
    Michel Lecendreux
    Alessandro Zuddas
    Ben Adeyi
    Paul Hodgkins
    Liza A. Squires
    David R. Coghill
    CNS Drugs, 2014, 28 : 1191 - 1203
  • [33] A pilot study for augmenting atomoxetine with methylphenidate: Safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
    Carlson G.A.
    Dunn D.
    Kelsey D.
    Ruff D.
    Ball S.
    Ahrbecker L.
    Allen A.J.
    Child and Adolescent Psychiatry and Mental Health, 1 (1)
  • [34] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    Coghill, David R.
    Banaschewski, Tobias
    Bliss, Caleb
    Robertson, Brigitte
    Zuddas, Alessandro
    CNS DRUGS, 2018, 32 (01) : 85 - 95
  • [35] Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
    Svanborg, Par
    Thernlund, Gunilla
    Gustafsson, Per A.
    Hagglof, Bruno
    Schacht, Alexander
    Kadesjo, Bjorn
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2009, 18 (12) : 725 - 735
  • [36] Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
    Pär Svanborg
    Gunilla Thernlund
    Per A. Gustafsson
    Bruno Hägglöf
    Alexander Schacht
    Björn Kadesjö
    European Child & Adolescent Psychiatry, 2009, 18
  • [37] Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder
    Amiri, Shahrokh
    Farhang, Sara
    Ghoreishizadeh, Mohammad Ali
    Malek, Ayyoub
    Mohammadzadeh, Soleiman
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (01) : 76 - 81
  • [38] Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review
    Hutchison, Shari L.
    Ghuman, Jaswinder K.
    Ghuman, Harinder S.
    Karpov, Irina
    Schuster, James M.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2016, 6 (05) : 317 - 334
  • [39] Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study
    Michelson, D
    Faries, D
    Wernicke, J
    Kelsey, D
    Kendrick, K
    Sallee, FR
    Spencer, T
    PEDIATRICS, 2001, 108 (05) : E83
  • [40] Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
    Shim, Se-Hoon
    Woo, Young Sup
    Kim, Ji Sun
    Heo, In Soo
    Yoon, Hee-Jung
    Sung, Hyung Mo
    Lee, Jonghun
    Bahk, Won-Myong
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (01) : 143 - 153
12345